HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Different types of GABA(A) receptors may mediate the anticonflict and response rate-decreasing effects of zaleplon, zolpidem, and midazolam in squirrel monkeys.

AbstractRATIONALE:
The role of different types of GABA(A) receptors in mediating anticonflict and response rate-decreasing effects of benzodiazepines in primate species is not known.
OBJECTIVE:
To examine the behavioral effects of the benzodiazepine-site, GABA(A) agonists zolpidem, zaleplon, and midazolam in the presence of two antagonists, flumazenil and beta-carboline-3-carboxylate-t-butyl ester (beta-CCt) in squirrel monkeys.
METHODS:
Two schedules of operant responding were used: (1) a multiple fixed-ratio (FR) schedule of food presentation involving punished and nonpunished behavior, and (2) an FR schedule of stimulus shock-termination.
RESULTS:
Midazolam (0.03-1.0 mg/kg), zolpidem (0.1-3.0 mg/kg), and zaleplon (0.1-3.0 mg/kg) increased rates of punished responding and decreased rates of nonpunished responding under the multiple schedule. Pretreatment with flumazenil (0.3-1.0 mg/kg) antagonized the anticonflict and response rate-decreasing effects of all three agonists. Pretreatment with beta-CCt (3-10 mg/kg) antagonized the anticonflict and rate-decreasing effects of midazolam, as well as the rate-decreasing effects of zolpidem and zaleplon. However, beta-CCt did not antagonize the anticonflict effects of zolpidem and zaleplon; instead, these effects of zolpidem and zaleplon were apparently enhanced in the presence of beta-CCt. Under the schedule of stimulus shock-termination, both flumazenil and beta-CCt antagonized zolpidem and zaleplon; however, the effects of beta-CCt were less consistent than the effects of flumazenil.
CONCLUSION:
In nonhuman primates, different types of GABAA receptors may mediate the anticonflict and the response rate-decreasing effects of the nonselective GABAA agonist midazolam and the selective GABAA1 agonists zolpidem and zaleplon.
AuthorsC A Paronis, E D Cox, J M Cook, J Bergman
JournalPsychopharmacology (Psychopharmacology (Berl)) Vol. 156 Issue 4 Pg. 461-8 (Aug 2001) ISSN: 0033-3158 [Print] Germany
PMID11498724 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Acetamides
  • Carbolines
  • GABA Antagonists
  • GABA Modulators
  • GABA-A Receptor Agonists
  • Hypnotics and Sedatives
  • Pyridines
  • Pyrimidines
  • Receptors, GABA-A
  • Flumazenil
  • Zolpidem
  • tert-butyl beta-carboline-3-carboxylate
  • Midazolam
  • zaleplon
Topics
  • Acetamides (pharmacology)
  • Animals
  • Carbolines (pharmacology)
  • Dose-Response Relationship, Drug
  • Flumazenil (pharmacology)
  • GABA Antagonists (pharmacology)
  • GABA Modulators (pharmacology)
  • GABA-A Receptor Agonists
  • Hypnotics and Sedatives (pharmacology)
  • Male
  • Midazolam (pharmacology)
  • Pyridines (pharmacology)
  • Pyrimidines (pharmacology)
  • Reaction Time (drug effects, physiology)
  • Receptors, GABA-A (physiology)
  • Saimiri
  • Zolpidem

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: